Hepatitis B is hyperendemic in Taiwan; more than 15% of adults are chronic carriers ofthe virus and longterm sequelae (chronic active hepatitis, cirrhosis, and hepatoceilular carcinoma) are common. A national immunisation programme was implemented in 1984 to tackle the problem. This entailed immunisation of newborn children, followed by susceptible school children and young adults. The programme, which has been in place for a decade, has resulted in a pronounced reduction in the prevalence of HBsAg among young children and seems to have led to a reduction in horizontal transmission among older children. (Gut 1996; 38 (suppl 2): S67-S68) Keywords: hepatitis B, immunisation, Taiwan. Background to the programme Taiwan was the site of many of the seminal studies on transmission of hepatitis B virus (HBV) infection -especially a series of studies that defined the importance of carrier mothers in maintaining the chain of hepatitis B infection and showed that perinatal transmission could be reduced by passive or active immunisation, or both.' 2 Early epidemiological studies in Taiwan showed that the hepatitis B surface antigen (HBsAg) carrier rate in the general population was between 15 and 20%, that a high proportion of carrier mothers were hepatitis B e antigen (HBeAg) positive, and that perinatal transmission was probably responsible for 40 to 50% of the carrier pool.3 4 In addition, chronic active hepatitis, cirrhosis, and hepatocellular carcinoma were common in the adult population and about three quarters of people with these diseases were chronically infected with HBV.5
Background to the programme Taiwan was the site of many of the seminal studies on transmission of hepatitis B virus (HBV) infection -especially a series of studies that defined the importance of carrier mothers in maintaining the chain of hepatitis B infection and showed that perinatal transmission could be reduced by passive or active immunisation, or both.' 2 Early epidemiological studies in Taiwan showed that the hepatitis B surface antigen (HBsAg) carrier rate in the general population was between 15 and 20%, that a high proportion of carrier mothers were hepatitis B e antigen (HBeAg) positive, and that perinatal transmission was probably responsible for 40 to 50% of the carrier pool.3 4 In addition, chronic active hepatitis, cirrhosis, and hepatocellular carcinoma were common in the adult population and about three quarters of people with these diseases were chronically infected with HBV. (Table II) .
While the coverage figures are most impressive, the key measure of the efficacy of the programme is its impact on the carrier rate among children. Cross sectional studies of sera collected from children born before and after the onset of the programme have shown a noticeable decline in the prevalence of HBsAg among children less than 5 years of age, a decline in the prevalence of HBsAg in babies born to highly infectious mothers from 90% in The success of the programme seems to be due to two factors: (a) support from the government, both in establishing the programme as a priority and mobilising the resources needed to implement it and in its careful design and implementation; (b) sufficient time allowed from planning, consultation with and education of opinion leaders, generation ofeducational material, and involving the private and public sectors.
Despite its success to date, much attention is being paid to improving the programme by education specifically targeted at less privileged groups, making access to immunisation more convenient, shortening the waiting times at public clinics, and improving data handling, so that parents of children who have failed to receive a dose of vaccine will receive regular reminders. 
